Back

Val122Ile familial transthyretin (TTR) amyloid cardiomyopathy in African-American patients has a worse prognosis than wild-type TTR amyloid cardiomyopathy.

29 August 2016 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster session 4 - Cardiomyopathies Cardiomyopathies ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Rodney H Falk

Brigham and Women's Hospital, Boston (United States of America)

14 More presentations in this session

Presentation thumbnail
Doctor R. Coppini (Florence, IT)
Abstract Slides
Presentation thumbnail
Mr D. Goncharik (Minsk, BY)
Abstract Slides
Presentation thumbnail
Doctor M. Kubanek (Prague, CZ)
Abstract Slides
Presentation thumbnail
Doctor A. Nomura (Tokyo, JP)
Abstract
Presentation thumbnail
Doctor T. d'Humieres (Creteil, FR)
Abstract Slides

Access the full session

Session thumbnail
Poster session 4 - Cardiomyopathies

The Event

Event poster

ESC Congress 2016

29 August 2016 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Cardiac transthyretin wild-type amyloidosis (ATTRwt): a prospective study of 400 patients followed at the Italian referral center.
28 August 2020
thumbnail
Webinar
New drugs in the treatment of amyloidosis
16 July 2025
thumbnail
Congress Presentation
Management decisions in genotype-positive and phenotype-negative Hereditary Transthyretin Amyloid Cardiomyopathy (hATTR-CM): an emerging clinical dilemma
20 May 2023
thumbnail
Congress Presentation
DPD scintigraphy fails to detect transthyretin cardiac amyloidosis in Val30Met mutation carriers with early onset disease.
30 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources